BeiGene Investor
BeiGene is a life sciences, biotechnology company.
Technology:
Cell_Therapies, Small Molecules
Industry:
PharmTech
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
2010-01-01
Employees Number:
5001-10000
Funding Status:
IPO
Number Of Exits:
1
Investors Number:
7
Total Funding:
5887000000
Estimated Revenue:
$1B to $10B
Last Funding Date:
2020-07-12
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership